Search results
2 sty 2024 · Tumor removal for dogs can cost anywhere from hundreds of dollars to tens of thousands of dollars, says Dr. Gary Richter, D.V.M., founder of Ultimate Pet Nutrition and owner of Holistic...
14 wrz 2024 · The contemporary percutaneous treatment of coronary artery disease typically involves initial lesion preparation with balloon angioplasty, followed by the deployment of a drug-eluting stent (DES) to provide an immediate scaffold and reduce the long-term risk of restenosis.
15 wrz 2022 · Post-physiological assessment and a decrease in physiological indices in the first 15 min after PCI are important for treating de novo lesions using the DCB strategy.
22 lis 2023 · DCB could be a novel, safe and effective treatment for de-novo coronary lesions exceeding 2.5 mm in diameter through a detailed analysis of OCT. Keywords: drug-coated balloon, optical coherence tomography, late lumen enlargement, de novo, coronary artery disease
Patients were eligible if they had an ischaemic de-novo lesion in a coronary artery or bypass graft that could be treated with drug-coated balloons, at least one risk factor for bleeding, and a reference vessel diameter of 2·5–4·0 mm.
24 cze 2024 · The ongoing REC-CAGEFREE I trial is the first randomized trial with a clinical endpoint to assess the efficacy and safety of primary DCB angioplasty for the treatment of de novo, non-complex lesions without vessel diameter restrictions.
3 lut 2019 · We analyzed the efficacy of drug coated balloons (DCB) as a stand-alone-therapy in de novo lesions of large coronary arteries. DCBs seem to be an attractive alternative for the stent-free interventional treatment of de novo coronary artery disease (CAD).
